International Journal of Clinical Pharmacy

, Volume 33, Issue 1, pp 44–52 | Cite as

Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care

  • Shubashini GnanasanEmail author
  • Kang Nee Ting
  • Kok Thong Wong
  • Salmiah Mohd Ali
  • Abdul Razak Muttalif
  • Claire Anderson
Research Article


Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential.


Action research Diabetes mellitus Individualised care Malaysia Pharmaceutical care Pharmacist Tuberculosis 


  1. 1.
    Harries DA, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health. 2010;15:659–63.PubMedCrossRefGoogle Scholar
  2. 2.
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2,000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 Observational Studies. PLoS Medicine. 2008;5:e152. doi: 10.1371/journal.pmed.0050152.PubMedCrossRefGoogle Scholar
  4. 4.
    Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–46.PubMedCrossRefGoogle Scholar
  5. 5.
    Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009;137:203–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234.PubMedCrossRefGoogle Scholar
  7. 7.
    Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80:634–9.PubMedGoogle Scholar
  8. 8.
    Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Khairul Annuar A. Tuberculosis in diabetes patients: A clinical perspective. Southeast Asian J Trop Med Public Health. 2005;36:213–20.PubMedGoogle Scholar
  9. 9.
    Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multi-drug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001;120:1514–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.PubMedCrossRefGoogle Scholar
  11. 11.
    Rampal S, Rampal L, Rahmat R, Md Zain A, Yee GL, Mohamed M, et al. Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia. Asia Pac J Public Health. 2010;22:194–202.PubMedGoogle Scholar
  12. 12.
    WHO. country health information profile. [Cited 2010, Aug 4]. Available from,
  13. 13.
    Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4:1230–45.CrossRefGoogle Scholar
  15. 15.
    World Health Organisation. An expanded DOTS framework for effective tuberculosis contro. Int J Tuberc Lung Dis. 2002;6:378–88.Google Scholar
  16. 16.
    Gnanasan S, Wong KT, Mohd Ali S, Ting KN, Anderson C. Pharmacist-led medication therapy adherence clinic: exploring views of health care professionals. Int J Pharm Pract. 2010;18(Suppl 1):S24–5.Google Scholar
  17. 17.
    Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ. 2003;327:837–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Tulip S, Campbell D. Evaluating pharmaceutical care in hospitals. Hosp Pharm. 2001;8:275–9.Google Scholar
  19. 19.
    Medical Research Coucil. A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC. 2000.Google Scholar
  20. 20.
    Gnanasan S, Ting KN, Wong KT, Mohd Ali S, Muttalif AR, Anderson C. Medication beliefs and concerns among patients with tuberculosis and diabetes mellitus. 16th international social pharmacy workshop. Pharm Pract (Internet). 2010;8(Suppl 1):1–136.Google Scholar
  21. 21.
    Gnanasan S, Wong KT, Mohd Ali S, Muttalif AR, Ting KN, Anderson C. Exploring the need for pharmaceutical care (PC) management of tuberculosis and diabetes mellitus (TBDM) in Malaysia. Abstracts of the PCNE 7th Working Conference. Pharm World Sci. 2009;31:503.Google Scholar
  22. 22.
    Meyer J. Qualitative research in health care. Using qualitative methods in health related action research. BMJ. 2000;320:178–81.PubMedCrossRefGoogle Scholar
  23. 23.
    Hart E, Bond M. Action research for health and social care: a guide to practice: Buckingham: Open University Press. 1995.Google Scholar
  24. 24.
    Tanna NK. Action Research: a valuable research technique for service delivery development. Pharm World Sci. 2005;27:4–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177:189–92.PubMedGoogle Scholar
  26. 26.
    Tanna N, Pitkin J, Anderson C. Development of the specialist menopause pharmacist (SMP) role within a research framework. Pharm World Sci. 2005;27:61–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMedGoogle Scholar
  28. 28.
    Clark PM, Karagoz T, Apikoglu-Rabus S, Vehbi IF. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm. 2007;64:497–506.PubMedCrossRefGoogle Scholar
  29. 29.
    Mitrzyk BM. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist. Pharmacotherapy. 2008;28:1243–54.PubMedCrossRefGoogle Scholar
  30. 30.
    Elliott RA, Ross-Degnan D, Adans AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: Adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.PubMedCrossRefGoogle Scholar
  31. 31.
    Struijs JN, Baan CA, Schellevis FG, Westert GP, van de Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6:84. doi: 10.1186/1472-6963-6-84.PubMedCrossRefGoogle Scholar
  32. 32.
    Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald M. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes 2004;2. 58 doi: 10.1186/1477-7525-2-58.
  33. 33.
    Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on education-related problems. Patient Educ Couns. 2007;65:407–15.PubMedCrossRefGoogle Scholar
  35. 35.
    Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55.PubMedCrossRefGoogle Scholar
  36. 36.
    Rao PV. Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diabetes Dev Ctries. 1999;19:79–86.Google Scholar
  37. 37.
    Kotokey RK, Bhattaharya D, Das P, Azad A, De A. Study of efficacy of DOTS in pulmonary tuberculosis patients with associated diabetes. Lung India. 2007;24:58–60.CrossRefGoogle Scholar
  38. 38.
    Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676–85.PubMedCrossRefGoogle Scholar
  39. 39.
    Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3:43–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf. 2007;16:1104–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749–55.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Shubashini Gnanasan
    • 1
    Email author
  • Kang Nee Ting
    • 2
  • Kok Thong Wong
    • 2
  • Salmiah Mohd Ali
    • 3
  • Abdul Razak Muttalif
    • 4
  • Claire Anderson
    • 1
  1. 1.University of NottinghamNottinghamUnited Kingdom
  2. 2.University of NottinghamSemenyihMalaysia
  3. 3.Universiti Teknologi MARAShah AlamMalaysia
  4. 4.Penang HospitalPenangMalaysia

Personalised recommendations